CollPlant Biotechnologies (CLGN) Return on Sales Growth (1y) (2018 - 2026)
CollPlant Biotechnologies (CLGN) Return on Sales Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 0.00 |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 0.00 |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 0.00 |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 0.00 |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | CollPlant Biotechnologies | 4.63 Mn | 4.63 Mn | -243,000.00 | -42.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 30, 2026 | -42.00 |
| Dec 31, 2025 | -370.00 |
| Sep 30, 2025 | 1,090.00 |
| Jun 30, 2025 | 0.00 |
| Mar 30, 2025 | -45.00 |
| Dec 31, 2024 | -82.00 |
| Sep 30, 2024 | -1,135.00 |
| Jun 30, 2024 | 17.00 |
| Mar 31, 2024 | 36.00 |
| Dec 31, 2023 | 387.00 |
| Sep 30, 2023 | 41.00 |
| Jun 30, 2023 | 64.00 |
| Dec 31, 2022 | 266.00 |
| Sep 30, 2022 | -555.00 |
| Jun 30, 2022 | -59.00 |
| Dec 31, 2021 | -736.00 |
| Sep 30, 2021 | 344.00 |
| Jun 30, 2021 | -2.00 |
| Mar 31, 2021 | -2.00 |
| Dec 31, 2020 | -39.00 |